TRX-818 sodium
Modify Date: 2023-01-11 18:23:23
TRX-818 sodium structure
|
Common Name | TRX-818 sodium | ||
|---|---|---|---|---|
| CAS Number | 1256037-62-3 | Molecular Weight | 409.213 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C16H11FNNa2O5P | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of TRX-818 sodiumTRX-818 sodium (Foslinanib sodium ) is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities, induces cancer cell apoptosis and inhibits cancer cell proliferation; also prevents tumor cell VM by blocking the formation of vasculogenic-like tubular structures through an as of yet undetermined mechanism of action. Liver Cancer Phase 2 Clinical |
| Name | Foslinanib Disodium |
|---|---|
| Synonym | More Synonyms |
| Description | TRX-818 sodium (Foslinanib sodium ) is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities, induces cancer cell apoptosis and inhibits cancer cell proliferation; also prevents tumor cell VM by blocking the formation of vasculogenic-like tubular structures through an as of yet undetermined mechanism of action. Liver Cancer Phase 2 Clinical |
|---|---|
| References | References View Related Products by Target Other Targets Liver Cancer |
| Molecular Formula | C16H11FNNa2O5P |
|---|---|
| Molecular Weight | 409.213 |
| Exact Mass | 409.010345 |
| 4(1H)-Quinolinone, 2-(3-fluorophenyl)-6-methoxy-5-(phosphonooxy)-, sodium salt (1:2) |
| Foslinanib Disodium |
| Disodium 2-(3-fluorophenyl)-6-methoxy-4-oxo-1,4-dihydro-5-quinolinyl phosphate |